These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2472025)

  • 21. Inositol lipid metabolism in human T lymphocytes activated via the T3 complex.
    Cockcroft S; Lamb JR; Zanders ED
    Immunology; 1987 Feb; 60(2):209-12. PubMed ID: 2950051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of PIP2 hydrolysis by aluminum fluoride in resting T cell subsets of normal and autoimmune-prone lpr mice.
    Coggeshall KM; Altman A
    J Immunol; 1989 Aug; 143(3):780-6. PubMed ID: 2545777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity.
    Yoshimura N; Matsui S; Hamashima T; Oka T
    Transplantation; 1989 Feb; 47(2):351-6. PubMed ID: 2465592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a novel immunosuppressive agent, FK506, on human B cell activation.
    Suzuki N; Sakane T; Tsunematsu T
    Clin Exp Immunol; 1990 Feb; 79(2):240-5. PubMed ID: 1690097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experiments.
    Fahr A; Hiestand P; Ryffel B
    Transplant Proc; 1990 Jun; 22(3):1116-24. PubMed ID: 2140916
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclosporin-A and the OKT3 monoclonal antibody exert their respective inhibitory and mitogenic activity on T cells by interacting with the same receptors.
    Palacios R
    J Clin Immunol; 1982 Jul; 2(3 Suppl):15S-19S. PubMed ID: 6982278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concanavalin A induces Ca2+ mobilization, but only minimal inositol phospholipid breakdown in mouse B cells.
    Bijsterbosch MK; Klaus GG
    J Immunol; 1986 Aug; 137(4):1294-9. PubMed ID: 3016090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different sensitivites of rat T-lymphocytes on cysteine effects during the response to mitogens.
    Dabrowski MP; Dabrowska BK; Ryzewski J
    Bull Acad Pol Sci Biol; 1975; 23(9):597-602. PubMed ID: 1082354
    [No Abstract]   [Full Text] [Related]  

  • 29. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive effect of leukotriene B(4) receptor antagonist in vitro.
    Morita H; Takeda K; Yagita H; Okumura K
    Biochem Biophys Res Commun; 1999 Oct; 264(2):321-6. PubMed ID: 10529362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A protective effect of FK506 in ischemically injured rat livers.
    Kawano K; Kim YI; Goto S; Ono M; Kobayashi M
    Transplantation; 1991 Jul; 52(1):143-5. PubMed ID: 1713362
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapamycin suppresses in vitro immunoglobulin production by human lymphocytes.
    Luo H; Chen H; Daloze P; Chang J; Wu J
    Transplant Proc; 1991 Aug; 23(4):2236-8. PubMed ID: 1871858
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506.
    Walliser P; Benzie CR; Kay JE
    Immunology; 1989 Nov; 68(3):434-5. PubMed ID: 2480331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis.
    Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S
    Inflamm Res; 2004 Oct; 53(10):544-50. PubMed ID: 15597149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cyclosporine A on early stages of T cell activation.
    Isakov N; Scholz W; Altman A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1186-8. PubMed ID: 3493569
    [No Abstract]   [Full Text] [Related]  

  • 36. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion.
    Woo J; Propper DJ; Macleod AM; Thomson AW
    Clin Exp Immunol; 1990 Dec; 82(3):462-8. PubMed ID: 1702375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat. A pilot study.
    Katz IA; Takizawa M; Jaffe II; Stein B; Fallon MD; Epstein S
    Transplantation; 1991 Sep; 52(3):571-4. PubMed ID: 1716801
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
    Isakov N; Altman A
    J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.